Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2024, 6(4); doi: 10.25236/IJFM.2024.060410.

Analyzing the sequelae of pelvic inflammatory disease from the theory of collateral disease

Author(s)

Tian Hou1, Xia Liu2

Corresponding Author:
Tian Hou
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Abstract

The incidence of sequelae of pelvic inflammatory disease is based on deficiency of collaterals and marked by six evil qi, which has the characteristics of "easy stagnation and easy stasis, deficiency and deficiency inclusion, easy entry and difficulty in coming out". Following the basic treatment principle of "taking tonic of collaterals as the use", guided by "the most appropriate tonic of all collaterals and deficiency and deficiency inclusion", the actual patients mainly take tonic collaterals, the deficient patients take tonic collaterals as the purpose, and the deficient patients take tonic collaterals as the appropriate treatment. Attention is paid to the application of tonic collaterals.It provides many ideas for clinical use of sequelae of pelvic inflammatory diseases.

Keywords

Sequelae of pelvic inflammatory disease; Collaterals; Collateral disease theory; Dredging drug

Cite This Paper

Tian Hou, Xia Liu. Analyzing the sequelae of pelvic inflammatory disease from the theory of collateral disease. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 4: 77-84. https://doi.org/10.25236/IJFM.2024.060410.

References

[1] Zhou Ying, LI Fengkui.Study on TCM syndrome differentiation and treatment of chronic pelvic inflammatory disease [J].Yunnan college of t raditional Chinese medicine, 2011, (02) : 48-53. DOI: 10.19288 / j.carol carroll nki. Issn 1000-2723.2011.02.015. 

[2] Zhang Dai. Progress in diagnosis and treatment of pelvic inflammatory disease [J]. Journal of Clinical Pharmacotherapies,2019,17(12):36-39+69.

[3] Sun Xiaohui, Gao Cong, Zhang Hong.Zhang Hong's experience in treating the sequelae of pelvic inflammatory disease with warm-Tong method based on "Yang transforming Qi and Yin forming" [J]. Review of Traditional Chinese Medicine, 2019, 29(06):190-193. DOI:10.13862/j.cn43-1446/r.2023.06.038.

[4] Wu Yiling. Collaterology [M]. Beijing: Science and Technology Press of China, 2004:3,5,161,162. 

[5] Zhu Yuyi, Lin Jie, PI XIxuan.Summary of Professor Lin Jie's experience in treating the sequelae of pelvic inflammatory disease with liver-stagnation and spleen-deficiency [J]. Chinese Modern Doctor, 2019,58(07):133-136.

[6] Wu Lin, Li Hua, Li Chenxi and so on.Professor Qin Guozheng's experience in treating gout based on "collaterals theory" [J]. Rheumatology and Arthritis, 2019,10(09):54-57.

[7] Wei S B. Ideas, methods and long-term management strategies of TCM prevention and treatment of pelvic inflammatory diseases and their sequelae [J].Journal of Beijing University of Chinese Medicine, 2019,46(09):1204-1212. 

[8] Wang T T, Chen Z J. Application of Tongluo drug in the treatment of tic disorder based on collaterals theory [J].Beijing Journal of Traditional Chinese Medicine, 2019,42(02):192-195. DOI:10.16025/j.1674-1307.2023.02.016. 

[9] Hu Yunyun, Deng Gaopi. Introduction of Deng Gaopi's experience in treating chronic pelvic pain after pelvic inflammatory disease from the theory of collaterals [J].Ploidy in the new medical, 2019 (6) : 336-338. The DOI: 10.13457 / j.carol carroll nki JNCM. 2019.06.104. 

[10] Yu Sagui, LV Xiaodong, Pang Lijian et al.Using traditional Chinese medicine image thinking to talk about collateral disease and tonic drugs [J]. Chinese Journal of Traditional Chinese Medicine, 202,37(02):750-752. (in Chinese) 

[11] Gu Ling, XU Xiaofeng, GE Hua et al.Treatment of sequelae of pelvic inflammatory diseases from the theory of Wumen Medicine [J]. Jiangsu Chinese Medicine,2015,47(12):72-74. (in Chinese) 

[12] Shi Yaxin, Yu Yue, Shi Wei.Based on the analysis method of t2dm with collaterals disease theory in the application of uterine adenomyosis [J]. China's basic medical journal of traditional Chinese medicine, 2021, 27 (8) : 1216-1219. The DOI: 10.19945 / j.carol carroll nki. Issn 1006-3250.2021.08.007. 

[13] Wu Yiling. Pathogenesis and pathogenesis of collaterals disease [J]. Journal of Difficult Diseases,2004(05):282-284. (in Chinese)

[14] Chen Jie, XU Xiaotong, FENG Ziqin et al.Based on complex epidemiology said briefly generalized anxiety disorder onset and treatment [J]. Journal of traditional Chinese medicine (TCM), and 2024,52 (02) : 9-12. DOI: 10.19664 / j.carol carroll nki. 1002-2392.240024.

[15] Zhan Jie, Liu Hui, GUO Xingyao et al. Treatment of sequelae of pelvic inflammatory disease based on collateral disease theory [J].D in henan, 2019, 33 (6) 6:867-870. The DOI: 10.16367 / j.i SSN. 1003-5028.2019.06.0216.

[16] Xuan Da-Ke, LIU Yuan-Xian, LI Xu-Na et al.Study on the principle of allergic rhinitis and characteristics of drug use [J]. Chinese Folk Therapy, 2019,29(15):5-8. (in Chinese) DOI:10.19621/j.cnki.11-3555/r.2021.1502.

[17] Zhang Lankun, Guo Weifeng, XIAO Jing et al.Clinical application of Tongluo drugs from Ye Tianshi's theory of "Tongluo for use" [J]. Journal of Chinese Medicine,2014,55(09):804-805+808. (in Chinese) DOI:10.13288/ J.11-2166 /r.2014.09.023.

[18] Zhang xz. Ye Tianshi treatment the clinical guidelines basis disease analysis [J]. Journal of medical in henan, 2014 (10) : 1890-1891. The DOI: 10.16367 / j.i SSN. 1003-5028.2014.10.019.

[19] Wang Fenfei, Han Yanhua, Zhou Lina et al. Han Yanhua's clinical experience in treating chronic pelvic pain [J].Shanghai Journal of Traditional Chinese Medicine,2019,53(05):38-39+49. DOI:10.16305/j.1007-1334.2019.05.009.

[20] Gao Liangliang, ZHANG Yanlin, ZHANG Peng et al. Quality evaluation of standard decoction of Dried ginger [J].Chinese experimental formula tuition, 2019, 25 (5) : 161-166. The DOI: 10.13422 / j.carol carroll nki syfjx. 20190317.

[21] Guo Yufei, Yang Hongjun, Wang Yanping et al.Apiaceae sheen of TCM antiplatelet aggregation effect research [J]. China foundation of traditional Chinese medicine medical journal, 2016, 22 (12) : 1629-1631 + 1693. DOI: 10.19945 / j.carol carroll nki. Issn 1006-3250.2016.12.018.

[22] Fang Yi, Zhang Qinshu, Chen Rong.Clinical application of Tongluo drugs of scorpion and centipede [J]. China Information Journal of Chinese Medicine,2013,20(01):88. (in Chinese)

[23] Li Guojun.Chinese Materia Medica [M]. Beijing: China Pharmaceutical Press.1996.

[24] Chen Wanrong.Chemical composition and clinical application of rattan Chinese medicine [J]. Straits Pharmacy, 2019,32(05):27-28. (in Chinese)

[25] Chen, Xi; Li, Qi; Kan, Xiao- Xi; Wang, Ya- Jie; Li, Yu- Jie; Yang, Qing; Xiao, Hong- Bin; Chen, Ying; Weng, Xiao- Gang; Cai, Wei- Yan; Zhu, Xiao- Xin .Extract of Caulis Spatholobi, a novel blocker targeting tumor cell- induced platelet aggregation, Inhibits breastcancermetastasis OncologyReports, 2016. Doi: 10.3892 / or. 2016.